Personalised Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% in Phase 3 Trial
October 23, 2026
MADRID — A personalised mRNA cancer vaccine combined with immunotherapy has reduced the risk of melanoma recurrence o…
.png)
ENGLISH ✅ INDIA ✅ GLOBAL✅
ADVERTISE OR NEWS👇
LANGUAGE: ENGLISH✅MALAYALAM✅
WHATS APP JOIN👇